2018
DOI: 10.1111/acps.12877
|View full text |Cite
|
Sign up to set email alerts
|

Increase in diagnosis of depressive disorders contributes to the increase in antidepressant use in adolescents

Abstract: The only issue studied that could explain increasing AD use in girls was increasing incidence of depressive disorders. Most adolescents with incident diagnosis of depressive disorders were not treated with ADs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
10
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(12 citation statements)
references
References 27 publications
2
10
0
Order By: Relevance
“…The temporal increases in incidence rates that we report for depression are, in terms of their magnitude, consistent with those reported from previous studies conducted in the UK [22] and in Norway [24]. In both sexes, incidence was higher at ages 13-16 and 17-19, but younger age groups saw larger relative increases.…”
Section: Discussionsupporting
confidence: 91%
“…The temporal increases in incidence rates that we report for depression are, in terms of their magnitude, consistent with those reported from previous studies conducted in the UK [22] and in Norway [24]. In both sexes, incidence was higher at ages 13-16 and 17-19, but younger age groups saw larger relative increases.…”
Section: Discussionsupporting
confidence: 91%
“…This is in line with previous studies conducted in EDs (4, 12). This is also consistent with an increase in self-reported symptoms of depression during adolescence reported in general populations (22), and longitudinal data collected in both primary and secondary health care services (23). Interestingly, in our study such increase was not associated with a corresponding rise in the number of diagnosed depressive disorders.…”
Section: Discussionsupporting
confidence: 86%
“…Finally, centrally acting sympathomimetics (ATC N06BA) are primarily used to treat ADHD. Not that there is no one-to-one relationship between a specific prescription drug and a diagnosis or problem (Skurtveit et al 2018;Wong et al 2016). For example, while selective serotonin reuptake inhibitors (SSRIs) are classified within the ATC classification system as antidepressants, they are also the preferred drug for treating pediatric anxiety disorders (Ask et al 2019;Wesselhoeft et al 2020).…”
Section: Life Course Outcomesmentioning
confidence: 99%